New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
08:37 EDTDDDuPont sees Nutrition and Health to have modest growth in Q3
Q3 Nutrition and Health operating earnings to be higher due to higher sales, mix enrichment and productivity. Sees Q3 Industrial Biosciences sales to up be modestly on continued enzyme demand in ethanol production. Sees Q3 Safety & Protection sales to be up modestly reflecting continuing demand by Asia and North America. Sees Q3 Electronics and Communications to have increased global photovoltaic module installations with mid-teens growth rate. Expects strong 2H in PV driven by installations in China. Q3 Electronics and Communications sales are expected to be slightly higher with operating earnings slightly lower. Sees Q3 Performance Materials sales flat due to GLS/Vinyls sale. Sees Q3 Performance Chemicals sales essentially flat. Sees 2H14 Agriculture sales to be modestly higher due to growth in insecticide volumes. Sees a similar Q3 loss as prior year followed by a strong Q4 for Agriculture. Comments taken from slides for Q2 earnings conference call.
News For DD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent DD news | >>
April 21, 2015
16:26 EDTDDOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
12:33 EDTDDOn The Fly: Top stock stories at midday
Subscribe for More Information
10:00 EDTDDDuPont sees potential for accelerated share repurchases for Chemours dividend
DuPont said it is determining what tool and mechanism to use to complete its share buyback related to Chemours, potentially using an ASR, noting there's also the potential for open market purchases. DuPont repeated that it expects to return to shareholders substantially all of the approximately $4B of one-time dividend proceeds from the spin-off of Chemours within 12-18 months of the separation.
09:26 EDTDDDuPont sees Q2 Performance Chemicals sales, operating earnings to be flat
Subscribe for More Information
09:25 EDTDDDuPont sees Q2 Industrial Biosciences sales about flat
In Industrial Biosciences, DuPont anticipates higher volumes will be offset by the negative impact of currency and softer U.S. biomaterials sales, resulting in Q2 sales that are about flat and operating earnings even with the prior year. In Nutrition and Health, sales are xpected to be high-single digits percent lower in Q2 as volume growth is more than offset by strong currency headwinds. Operating earnings in Nutrition and Health are expected to be low-teens percent lower primarily due to the negative impact of currency. In Agriculture, Q2 sales are seen mid-single-digits percent lower and operating earnings are expected to be down low-to-mid-single digits percent.
09:22 EDTDDDuPont sees Q2 Safety & Protection sales down mid-single digits percent
Subscribe for More Information
09:21 EDTDDDuPont sees Q2 Electronics & Communications sales down about low-teens percent
Subscribe for More Information
09:20 EDTDDDuPont sees Q2 Performance Materials sales down about 'low-teens' percent
Subscribe for More Information
06:09 EDTDDDuPont reports sees Chemours spinoff on track for middle of FY15
Subscribe for More Information
06:06 EDTDDDuPont sees FY15 EPS at low end of $4.00-$4.20, consensus $4.05
Subscribe for More Information
06:04 EDTDDDuPont reports Q1 EPS $1.34, consensus $1.31
Reports Q1 revenue $9.17B, consensus $9.41B.
06:02 EDTDDDuPont raises Q2 dividend to 49c per share from 47c per share
DuPont declared a Q2 common stock dividend of 49c per share payable June 12, to stockholders of record May 15. This represents a 4% increase over the 47c paid last quarter. The dividend is payable July 24, to stockholders of record July 10.
April 20, 2015
15:37 EDTDDNotable companies reporting before tomorrow's open
Subscribe for More Information
15:03 EDTDDDuPont technical comments before earnings
Subscribe for More Information
April 17, 2015
11:38 EDTDDCelanese hits new 52-week high after raising FY15 profit outlook
Subscribe for More Information
April 16, 2015
12:38 EDTDDDuPont solicits bids for Delaware hotel, country club, Bloomberg says
DuPont has begun soliciting bids for its Hotel DuPont and DuPont Country Club in Wilmington, Delaware, reports Bloomberg, citing a person familiar with the auction. The move would dovetail with the wishes of Nelson Peltz' Trian Fund Management, which claims the company should be broken up due to $4B in excess costs. Reference Link
08:24 EDTDDDuPont sends letter to shareholders, urging vote FOR DuPont's 12 directors
Subscribe for More Information
April 14, 2015
07:58 EDTDDDuPont CEO says Peltz wrongly focusing on short-term, WSJ reports
In an interview with The Wall Street Journal, DuPont CEO Ellen Kullman argued that Trian Fund Management's Nelson Peltz is pushing a short-term agenda, stating “Can you cut costs and create a bump short-term? Yes, but where are you going to be in two years, in five years? Do you exist in 10?” Kullman added that Trian lacks the expertise and the patience needed to guide a company whose products may require a decade or more to launch, the Journal added. Reference Link
April 13, 2015
09:53 EDTDDTrian's Garden says 'very confident' in winning DuPont board seats
Ed Garden, Chief Investment Officer of Trian Partners, is speaking on CNBC.
09:52 EDTDDTrian's Garden says something wrong with DuPont R&D spending
Subscribe for More Information
1 | 2 | all recent DD news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use